Full-time physioxic culture conditions promote MSC proliferation more than hypoxic preconditioning
Cells that are cultured and handled in traditional hyperoxic room air experience a dramatic shift in oxygen levels when injected in vivo. It has been reported that hypoxic pre-conditioning of mesenchymal stromal cells (MSC) in culture can increase cell survival in vivo after administration. Publishe...
Saved in:
Published in | Cytotherapy (Oxford, England) Vol. 21; no. 5; pp. S73 - S74 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.05.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 1465-3249 1477-2566 |
DOI | 10.1016/j.jcyt.2019.03.470 |
Cover
Abstract | Cells that are cultured and handled in traditional hyperoxic room air experience a dramatic shift in oxygen levels when injected in vivo. It has been reported that hypoxic pre-conditioning of mesenchymal stromal cells (MSC) in culture can increase cell survival in vivo after administration. Published hypoxic pre-treatments subject room-air expanded cells to lower oxygen atmospheric conditions for lengths of time that range from 15 minutes to 36 hours, followed by another period of high oxygen exposure in room air conditions before administration. Some regimens use cobalt compounds to deplete HIF-1a rather than the cell environment. We previously showed that Human bone marrow MSC yields are improved by enclosing cell-handling processes as well as incubation for a full-time controlled physioxic atmosphere.
To use the Xvivo System (BioSpherix), with fully-enclosed and environmentally-controlled cell incubation and handling chambers, to compare different hypoxic pre-conditioning regimens to full-time physioxic conditions for MSC yields and subjected to subsequent physioxic conditions as if injected venously. Our null hypothesis was that the different culture conditions make no difference to MSC morphology and proliferation rates.
MSC were incubated for 1-36 hours at 1% O2 before return to traditional supraphysioxic room air incubator oxygen levels for 24 hours. The cells were then incubated at 5% O2 (venous O2 levels) as if injected in vivo. These conditions were compared with unbroken 5% O2 for both cell handling and culture. Using an immersion oxygen probe, we recorded vessel headspace and pericellular medium oxygen levels during each regimen. For 72 hours in culture to 5% O2, we assayed cells for changes in cell division rates and final cell yield. MSC pericellular O2 levels lagged far behind atmospheric oxygen level changes, so MSC experienced low oxygen conditions for far less time than the pre-conditioning period. Unbroken oxygen conditions were more favorable for keeping MSC in the cell cycle than any pre-conditioning regiment, disproving the null hypothesis. We concluded that hypoxic pre-conditioning is not as favorable for MSC yields as full-time physioxic conditions for cell handling and incubation. |
---|---|
AbstractList | Cells that are cultured and handled in traditional hyperoxic room air experience a dramatic shift in oxygen levels when injected in vivo. It has been reported that hypoxic pre-conditioning of mesenchymal stromal cells (MSC) in culture can increase cell survival in vivo after administration. Published hypoxic pre-treatments subject room-air expanded cells to lower oxygen atmospheric conditions for lengths of time that range from 15 minutes to 36 hours, followed by another period of high oxygen exposure in room air conditions before administration. Some regimens use cobalt compounds to deplete HIF-1a rather than the cell environment. We previously showed that Human bone marrow MSC yields are improved by enclosing cell-handling processes as well as incubation for a full-time controlled physioxic atmosphere.
To use the Xvivo System (BioSpherix), with fully-enclosed and environmentally-controlled cell incubation and handling chambers, to compare different hypoxic pre-conditioning regimens to full-time physioxic conditions for MSC yields and subjected to subsequent physioxic conditions as if injected venously. Our null hypothesis was that the different culture conditions make no difference to MSC morphology and proliferation rates.
MSC were incubated for 1-36 hours at 1% O2 before return to traditional supraphysioxic room air incubator oxygen levels for 24 hours. The cells were then incubated at 5% O2 (venous O2 levels) as if injected in vivo. These conditions were compared with unbroken 5% O2 for both cell handling and culture. Using an immersion oxygen probe, we recorded vessel headspace and pericellular medium oxygen levels during each regimen. For 72 hours in culture to 5% O2, we assayed cells for changes in cell division rates and final cell yield. MSC pericellular O2 levels lagged far behind atmospheric oxygen level changes, so MSC experienced low oxygen conditions for far less time than the pre-conditioning period. Unbroken oxygen conditions were more favorable for keeping MSC in the cell cycle than any pre-conditioning regiment, disproving the null hypothesis. We concluded that hypoxic pre-conditioning is not as favorable for MSC yields as full-time physioxic conditions for cell handling and incubation. Background & AimCells that are cultured and handled in traditional hyperoxic room air experience a dramatic shift in oxygen levels when injected in vivo. It has been reported that hypoxic pre-conditioning of mesenchymal stromal cells (MSC) in culture can increase cell survival in vivo after administration. Published hypoxic pre-treatments subject room-air expanded cells to lower oxygen atmospheric conditions for lengths of time that range from 15 minutes to 36 hours, followed by another period of high oxygen exposure in room air conditions before administration. Some regimens use cobalt compounds to deplete HIF-1a rather than the cell environment. We previously showed that Human bone marrow MSC yields are improved by enclosing cell-handling processes as well as incubation for a full-time controlled physioxic atmosphere. AIMsTo use the Xvivo System (BioSpherix), with fully-enclosed and environmentally-controlled cell incubation and handling chambers, to compare different hypoxic pre-conditioning regimens to full-time physioxic conditions for MSC yields and subjected to subsequent physioxic conditions as if injected venously. Our null hypothesis was that the different culture conditions make no difference to MSC morphology and proliferation rates.Methods, Results & ConclusionMSC were incubated for 1-36 hours at 1% O2 before return to traditional supraphysioxic room air incubator oxygen levels for 24 hours. The cells were then incubated at 5% O2 (venous O2 levels) as if injected in vivo. These conditions were compared with unbroken 5% O2 for both cell handling and culture. Using an immersion oxygen probe, we recorded vessel headspace and pericellular medium oxygen levels during each regimen. For 72 hours in culture to 5% O2, we assayed cells for changes in cell division rates and final cell yield. MSC pericellular O2 levels lagged far behind atmospheric oxygen level changes, so MSC experienced low oxygen conditions for far less time than the pre-conditioning period. Unbroken oxygen conditions were more favorable for keeping MSC in the cell cycle than any pre-conditioning regiment, disproving the null hypothesis. We concluded that hypoxic pre-conditioning is not as favorable for MSC yields as full-time physioxic conditions for cell handling and incubation. |
Author | Yerden, R. Henn, A. Darou, S. |
Author_xml | – sequence: 1 givenname: A. surname: Henn fullname: Henn, A. – sequence: 2 givenname: S. surname: Darou fullname: Darou, S. – sequence: 3 givenname: R. surname: Yerden fullname: Yerden, R. |
BookMark | eNqFkctKxDAUhoMoeH0BV32B1lyaXkQEGRwVRlyo65BmTp3UTlKSjNi3Nx3FhaCu8kPy_Um-c4h2jTWA0CnBGcGkOOuyTo0ho5jUGWZZXuIddEDyskwpL4rdKRc8ZTSv99Gh9x3GFFcVP0DNfNP3adBrSIbV6LV91ypRmz5sHCTKmqUO2hqfDM6ubYDk_nE25V634OS0laxtPBlW0iSrcdjig4NvUpuXY7TXyt7Dydd6hJ7n10-z23TxcHM3u1qkinKC07bhWJIip1S2uK5yUBhKmlcEGG0LKmvJGaF1jC1rOM_zBiTjpeRFo6oIsyNUffYqZ7130Aqlw_aNwUndC4LF5Ep0YnIlJlcCMxFdRZT-QAen19KNf0MXnxDET71pcMIrDUbBUkcBQSyt_hu__IGrXhutZP8KI_jObpyJugQRngosHqcJTgMkNcMFJVUsOP-94L_bPwBiDLBB |
CitedBy_id | crossref_primary_10_3390_ijms23168905 crossref_primary_10_3390_ijms22073576 |
ContentType | Journal Article |
Copyright | 2019 |
Copyright_xml | – notice: 2019 |
DBID | AAYXX CITATION |
DOI | 10.1016/j.jcyt.2019.03.470 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1477-2566 |
EndPage | S74 |
ExternalDocumentID | 10_1016_j_jcyt_2019_03_470 S1465324919306218 1_s2_0_S1465324919306218 |
GroupedDBID | --- --M .1- .FO .~1 1P~ 1~. 29F 36B 4.4 457 4G. 53G 5GY 5VS 7-5 8P~ AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AATTM AAXKI AAXUO AAYWO ABDBF ABGSF ABJNI ABMAC ABMZM ABUDA ABXDB ACDAQ ACGEJ ACGFS ACIEU ACRLP ACUHS ACVFH ADBBV ADCNI ADCVX ADEZE ADXPE AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFKVX AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGRDE AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AJWEG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AWYRJ AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS COF CS3 DU5 EAP EBC EBS EFJIC EFKBS EJD EMB EMK EMOBN ESX F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN GBLVA H13 HVGLF HZ~ KOM LUGTX M44 MO0 O-L O9. OAUVE OK~ P-8 P-9 P2P PC. Q38 R2- ROL SDF SPCBC SSH SSI SSU SSZ SV3 T5K TDBHL TFW Z5R ~G- AACTN AFCTW AFKWA AJOXV AMFUW AAIAV ABLVK ABYKQ AJBFU DOVZS EFLBG LCYCR AAYXX AGRNS CITATION |
ID | FETCH-LOGICAL-c2510-fb50a16422af0984ec0e72481e32f62a9a53129f62f3b5544bea357a56bc8fb53 |
IEDL.DBID | AIKHN |
ISSN | 1465-3249 |
IngestDate | Thu Apr 24 23:12:48 EDT 2025 Tue Jul 01 03:06:24 EDT 2025 Fri Feb 23 02:16:03 EST 2024 Sun Feb 23 10:18:47 EST 2025 Tue Aug 26 17:16:31 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2510-fb50a16422af0984ec0e72481e32f62a9a53129f62f3b5544bea357a56bc8fb53 |
ParticipantIDs | crossref_citationtrail_10_1016_j_jcyt_2019_03_470 crossref_primary_10_1016_j_jcyt_2019_03_470 elsevier_sciencedirect_doi_10_1016_j_jcyt_2019_03_470 elsevier_clinicalkeyesjournals_1_s2_0_S1465324919306218 elsevier_clinicalkey_doi_10_1016_j_jcyt_2019_03_470 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2019 |
PublicationDateYYYYMMDD | 2019-05-01 |
PublicationDate_xml | – month: 05 year: 2019 text: May 2019 |
PublicationDecade | 2010 |
PublicationTitle | Cytotherapy (Oxford, England) |
PublicationYear | 2019 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
SSID | ssj0020885 |
Score | 2.209951 |
Snippet | Cells that are cultured and handled in traditional hyperoxic room air experience a dramatic shift in oxygen levels when injected in vivo. It has been reported... Background & AimCells that are cultured and handled in traditional hyperoxic room air experience a dramatic shift in oxygen levels when injected in vivo. It... |
SourceID | crossref elsevier |
SourceType | Enrichment Source Index Database Publisher |
StartPage | S73 |
SubjectTerms | Advanced Basic Science Other |
Title | Full-time physioxic culture conditions promote MSC proliferation more than hypoxic preconditioning |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1465324919306218 https://www.clinicalkey.es/playcontent/1-s2.0-S1465324919306218 https://dx.doi.org/10.1016/j.jcyt.2019.03.470 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NSxwxFH_oeuml9JOubSWH4qWmm0kmmZmjLJXVoggqeAtJJqErsg5dC91L__a-TDKrpWLBW2bIjxlekvcRfu89gE-uVkKVitOmrRpatnVBjRKcMq9Ca1lAtRkDxeMTNbsojy7l5QZMh1yYSKvMuj_p9F5b5zeTLM1JN59PzopYGgyjB3RBmEJLtQlbXDRKjmBr__Db7GQdd-FBkinJSNIIyLkzieZ15VaRUln0tU7L2LP4Ift0z-YcvIDn2Vkk--l_XsKGX7yC3dNUbXq1R87vkqeWe2SXnN7VoV69BhvDSxqbx5P-_uLm19yRVGnDEwyD28TWIl3PyPPk-Gwax9eR7NKvF4kkXBLv1sn3VdfDuz6ATkg0em_g4uDr-XRGc0sF6tCRYTRYyQxGSJybwJq69I75ipd14QUPipvG4JnkDQ6DsOhplNYbISsjlXU1gsVbGC1uFv4dEG-CdNJWVjqGFi40ZZDCW2OaNrDCt2MoBkFql-uNx7YX13ogll3pKHwdha-Z0Cj8MXxeY7pUbePR2WJYHz3kkaLm02gMHkVVD6H8Mh_epS70kmum_9lgY5Br5F979D9f3H4i7j08i0-JXvkBRrc_fvqP6ALd2h3Y_PK72Mkb_Q-AWwfV |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZpemgvpU-6TR86lFwadWW9bB_L0rBtsyGQDeQmJFkiG8LGdFPIXvrbO2PZm5aGFHoTtj5sRtI8xDczhLwPlZFGGcHqpqyZaqqCOSMF49GkxvMEahMDxdmhmZ6or6f6dItMhlwYpFX2uj_r9E5b90_GvTTH7WIxPi6wNBhED-CCcAOW6h65r7Qskdf38eeG5yHgGOmcYqQZTu8zZzLJ6zyskVBZdJVOFXYsvs06_WZx9h-TR72rSD_lv3lCtuLyKdk9yrWm13t0fpM6tdqju_Topgr1-hnxGFwybB1Pu9uLy-tFoLnORqQQBDeZq0Xbjo8X6ex4guMLpLp0q0WRgkvxZp2erdsO3nbhc0aCyXtOTvY_zydT1jdUYAHcGM6S19xBfCSES7yuVAw8lkJVRZQiGeFqBydS1DBM0oOfoXx0UpdOGx8qAMsXZHt5uYwvCY0u6aB96XXgYN9SrZKW0TtXN4kXsRmRYhCkDX21cWx6cWEHWtm5ReFbFL7l0oLwR-TDBtPmWht3zpbD-tghixT0ngVTcCeqvA0VV_3RXdnCroTl9q_tNSJ6g_xjh_7ji6_-E_eOPJjOZwf24Mvhtx3yEN9kouVrsn31_Ud8A87QlX_bbfZfwq0IoA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Full-time+physioxic+culture+conditions+promote+MSC+proliferation+more+than+hypoxic+preconditioning&rft.jtitle=Cytotherapy+%28Oxford%2C+England%29&rft.au=Henn%2C+A.&rft.au=Darou%2C+S.&rft.au=Yerden%2C+R.&rft.date=2019-05-01&rft.issn=1465-3249&rft.volume=21&rft.issue=5&rft.spage=S73&rft.epage=S74&rft_id=info:doi/10.1016%2Fj.jcyt.2019.03.470&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jcyt_2019_03_470 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F14653249%2FS1465324919X00067%2Fcov150h.gif |